SG Americas Securities’s AbbVie ABBV Stock Holding History

SG Americas Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-202,200	Closed	-$14K	–	3167
2025 Q4	$14K	Sell	202,200 -8,300	-4%	-$1.89M	﹤0.01%	3493
2025 Q3	$153K	Buy	210,500 +15,000	+8%	+$3.05M	﹤0.01%	2892
2025 Q2	$1.27M	Sell	195,500 -6,100	-3%	-$1.13M	0.01%	1005
2025 Q1	$852K	Buy	201,600 +69,500	+53%	+$13.5M	﹤0.01%	1305
2024 Q4	$39K	Hold	132,100	–	–	﹤0.01%	2947
2024 Q3	$86K	Hold	132,100	–	–	﹤0.01%	3119
2024 Q2	$253K	Sell	132,100 -58,200	-31%	-$9.64M	﹤0.01%	2050
2024 Q1	$292K	Sell	190,300 -62,600	-25%	-$10.8M	﹤0.01%	1709
2023 Q4	$499K	Sell	252,900 -6,100	-2%	-$889K	﹤0.01%	1484
2023 Q3	$960K	Buy	259,000 +6,100	+2%	+$895K	0.01%	1302
2023 Q2	$2.09M	Buy	252,900 +36,200	+17%	+$5.31M	0.02%	724
2023 Q1	$759K	Buy	216,700 +125,100	+137%	+$19.1M	0.01%	1376
2022 Q4	$526K	Buy	91,600 +19,000	+26%	+$2.91M	0.01%	1489
2022 Q3	$1.13M	Sell	72,600 -50,000	-41%	-$7.17M	0.01%	934
2022 Q2	$817K	Buy	122,600 +67,700	+123%	+$10.3M	0.01%	1481
2022 Q1	$109K	Sell	54,900 -230,400	-81%	-$33.5M	﹤0.01%	2731
2021 Q4	$30K	Buy	285,300 +167,300	+142%	+$19.8M	﹤0.01%	3238
2021 Q3	$96K	Hold	118,000	–	–	﹤0.01%	3672
2021 Q2	$105K	Hold	118,000	–	–	﹤0.01%	2642
2021 Q1	$215K	Sell	118,000 -580,000	-83%	-$62M	﹤0.01%	2635
2020 Q4	$423K	Hold	698,000	–	–	﹤0.01%	2101
2020 Q3	$2.43M	Sell	698,000 -22,500	-3%	-$2.12M	0.02%	636
2020 Q2	$2.4M	Sell	720,500 -301,000	-29%	-$26.5M	0.02%	707
2020 Q1	$7.4M	Sell	1,021,500 -559,400	-35%	-$47.6M	0.07%	262
2019 Q4	$1.3M	Buy	1,580,900 +192,900	+14%	+$16M	0.01%	1091
2019 Q3	$2.92M	Buy	1,388,000 +1,086,300	+360%	+$74.5M	0.02%	710
2019 Q2	$2.61M	Sell	301,700 -35,000	-10%	-$2.75M	0.02%	855
2019 Q1	$2.45M	Sell	336,700 -338,000	-50%	-$27.7M	0.02%	740
2018 Q4	$725K	Buy	674,700 +100,000	+17%	+$8.79M	0.01%	1581
2018 Q3	$730K	Buy	574,700 +35,000	+6%	+$3.32M	0.01%	1914
2018 Q2	$846K	Sell	539,700 -122,700	-19%	-$12M	0.01%	1600
2018 Q1	$1.5M	Sell	662,400 -1,053,000	-61%	-$116M	0.01%	1049
2017 Q4	$1.11M	Buy	1,715,400 +230,000	+15%	+$21.7M	0.01%	1305
2017 Q3	$1.02M	Buy	1,485,400 +525,800	+55%	+$40M	0.01%	1246
2017 Q2	$856K	Buy	959,600 +261,600	+37%	+$17.6M	0.01%	1513
2017 Q1	$1.08M	Buy	698,000 +472,100	+209%	+$29.7M	0.01%	1316
2016 Q4	$314K	Hold	225,900	–	–	﹤0.01%	2001
2016 Q3	$377K	Sell	225,900 -952,100	-81%	-$61.6M	﹤0.01%	1956
2016 Q2	$9.19M	Buy	1,178,000 +1,022,100	+656%	+$62.3M	0.07%	228
2016 Q1	$349K	Sell	155,900 -530,700	-77%	-$29.6M	﹤0.01%	1923
2015 Q4	$394K	Buy	+686,600	New	+$39.5M	﹤0.01%	1755
2015 Q3	–	Sell	-190,700	Closed	-$166K	–	2030
2015 Q2	$166K	Buy	190,700 +105,300	+123%	+$6.87M	﹤0.01%	2068
2015 Q1	$74K	Buy	85,400 +1,200	+1%	+$72.5K	﹤0.01%	2324
2014 Q4	$59K	Hold	84,200	–	–	﹤0.01%	2994
2014 Q3	$128K	Hold	84,200	–	–	﹤0.01%	2256
2014 Q2	$135K	Buy	+84,200	New	+$4.42M	﹤0.01%	2222

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SG Americas Securities's ABBV Position: Q1 2026 in Review

SG Americas Securities increased its AbbVie (ABBV) stake by 117% in Q1 2026, buying an estimated $136M and bringing the position to 1,135,261 shares worth $247M. The position accounts for 0.27% of the portfolio, ranked #51.

SG Americas Securities first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

SG Americas Securities held 1,135,261 shares of AbbVie worth $247M as of Q1 2026.
SG Americas Securities bought 612,667 AbbVie shares in Q1 2026, an estimated $136M.
AbbVie made up 0.27% of SG Americas Securities's portfolio in Q1 2026, its #51 holding.
SG Americas Securities first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.